Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 09:49AM ET
43.04
Dollar change
+0.06
Percentage change
0.14
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y6.75% Shs Outstand Perf Week-0.09%
SponsorState Street (SPDR) ETF Type Tagsequity Return% 3Y-3.72% Total Holdings43 Perf Month-4.19%
Fund Family Bond Type Tagspharmaceutical Return% 5Y1.95% AUM219.07M Perf Quarter2.67%
IndexS&P Pharmaceuticals Sel Industry Indx Average Maturity Tags- Return% 10Y NAV% Perf Half Y7.63%
Index Weighting Commodity Type Tags- Return% SI NAV/sh Perf Year6.19%
Active/Passive Quant Type Tags- Flows% 1M1.03% 52W Range34.67 - 45.62 Perf YTD3.41%
Dividend TTM0.59 (1.37%) ESG Type Tags- Flows% 3M-3.71% 52W High-5.66% Beta0.77
Dividend Ex-DateDec 18, 2023 Dividend Type Sector/Theme Flows% YTD-4.58% 52W Low24.14% ATR (14)0.54
Expense0.35% Structure Type Region Flows% 1Y RSI (14)49.66 Volatility1.29% 1.11%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.27 Prev Close42.98
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume44.98K Price43.04
SMA20-0.12% SMA50-0.52% SMA2004.78% Trades Volume1,185 Change0.14%
Jun-17-21 11:00AM
Oct-14-20 09:01AM
Aug-11-20 03:29PM
Jun-04-20 01:00PM
May-22-20 07:46AM
11:05AM Loading…
Feb-07-20 11:05AM
Jan-15-20 01:55PM
Jan-13-20 01:31PM
Jan-08-20 11:12AM
Dec-27-19 02:19PM
Dec-26-19 02:30PM
Nov-08-19 08:00AM
Nov-06-19 11:00AM
Oct-30-19 10:43AM
Oct-26-19 06:00AM
12:21PM Loading…
Oct-15-19 12:21PM
Oct-13-19 05:15PM
Aug-27-19 04:11PM
Aug-22-19 11:12AM
Aug-07-19 10:59AM
Jul-14-19 11:00AM
Jul-09-19 05:39PM
Jul-08-19 10:42AM
Jul-05-19 04:22PM
01:43PM
Jun-26-19 11:00AM
Jun-25-19 06:01PM
07:42AM
Jun-17-19 04:01PM
Jun-10-19 07:51AM
05:40PM Loading…
May-14-19 05:40PM
May-13-19 02:59PM
May-09-19 10:05AM
May-02-19 02:28PM
Apr-23-19 03:11PM
Apr-22-19 08:00AM
Apr-19-19 08:02AM
Apr-09-19 02:14PM
Apr-03-19 12:23PM
Mar-01-19 08:00AM
Feb-28-19 04:43PM
Feb-15-19 02:16PM
Feb-07-19 11:15AM
Jan-29-19 07:29AM
Jan-23-19 11:33AM
Jan-06-19 09:32AM
Dec-31-18 02:30PM
Dec-21-18 12:55PM
Dec-17-18 12:25PM
Dec-14-18 09:55AM
Nov-19-18 01:25PM
Nov-12-18 03:46PM
Nov-08-18 01:00PM
Nov-07-18 04:28PM
Oct-29-18 08:50AM
Oct-25-18 10:39AM
Oct-24-18 11:59AM
Oct-22-18 03:30PM
Oct-15-18 12:41PM
Oct-12-18 06:00AM
Sep-24-18 09:52AM
Sep-06-18 04:56PM
Aug-13-18 04:07PM
Aug-02-18 07:29AM
Jul-20-18 06:00AM
Jul-19-18 10:14AM
Jul-09-18 07:13AM
Jul-03-18 03:19PM
Jun-08-18 01:19PM
Jun-04-18 11:01AM
10:30AM
May-14-18 08:41AM
Apr-02-18 12:12PM
Mar-12-18 12:16PM
Feb-01-18 07:29AM
Jan-30-18 10:29AM
Jan-25-18 11:10AM
Jan-23-18 01:52PM
Jan-22-18 09:01AM
Jan-19-18 09:35AM
Jan-18-18 10:47AM
Jan-17-18 04:35PM
Jan-11-18 12:58PM
10:32AM
Jan-10-18 05:59PM
Dec-28-17 10:31AM
Nov-20-17 07:05AM
Nov-06-17 12:00PM
Oct-26-17 02:11PM
Oct-24-17 06:06PM
Oct-17-17 10:26AM
Oct-16-17 12:33PM
Sep-20-17 11:47AM
Sep-19-17 05:09PM
Sep-11-17 07:36AM
Sep-04-17 10:36AM
Aug-30-17 10:37AM
Aug-23-17 09:08AM
Aug-21-17 02:36PM
Aug-11-17 08:42AM
SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").